Rick W. Allen sold Cigna Corp (NYSE: CI)
Rick W. Allen (R-GA), a U.S. Representative, has disclosed 1 trade in Cigna Corp (CI) since 2018, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Rick W. Allen sold $15,001 - $50,000 of Cigna Corp (NYSE: CI) on February 7, 2018. Since that trade, CI is up +61.88% against the S&P 500 up +214.82%, an outperformance of -152.94%.
Data updated
Rick W. Allen's CI trades vs the price
CI is up +61.88% since Rick W. Allen sold on February 7, 2018, versus +214.82% for the S&P 500.
Performance since this trade
All Rick W. Allen CI trades
Rick W. Allen & CI trading FAQ
Is it legal for Rick W. Allen to trade Cigna Corp (CI) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Cigna Corp (CI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Rick W. Allen sell CI?
Rick W. Allen disclosed a sale of $15,001 - $50,000 of Cigna Corp (CI) on February 7, 2018, according to public STOCK Act filings.
How has CI performed since Rick W. Allen's trade?
Since Rick W. Allen sold CI on February 7, 2018, the stock is up +61.88%, versus +214.82% for the S&P 500 over the same period, an outperformance of -152.94%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CI trades?
Quantellect tracks every disclosed congressional trade in Cigna Corp (CI) on the Cigna Corp congressional trading page, which aggregates filings across all members of Congress.
Rick W. Allen's CI tradesAll congressional filings for Cigna CorpRick W. Allen's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.